What sector does Kiniksa Pharmaceuticals Ltd (KNSA) operate in?
Kiniksa Pharmaceuticals Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Kiniksa Pharmaceuticals Ltd (KNSA) current stock price?
As of the latest data, Kiniksa Pharmaceuticals Ltd stock price is $26.03, with a previous close of $26.72. Kiniksa Pharmaceuticals Ltd lost -$0.69 in the last trading session, representing a -2.58% loss.
What is Kiniksa Pharmaceuticals Ltd (KNSA) current market capitalization?
Kiniksa Pharmaceuticals Ltd market cap is approximately 1.09 billion.
What is Kiniksa Pharmaceuticals Ltd (KNSA) Earnings Per Share (EPS)?
The trailing EPS is -$0.60, and the forward EPS is $1.92.
What is Kiniksa Pharmaceuticals Ltd (KNSA) EBITDA?
Kiniksa Pharmaceuticals Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -18.90 million.
Does Kiniksa Pharmaceuticals Ltd (KNSA) dividends?
No. Kiniksa Pharmaceuticals Ltd does not pay a dividend.
How did Kiniksa Pharmaceuticals Ltd (KNSA) perform in its most recent earnings report?
In the last report (December 31, 2024), Kiniksa Pharmaceuticals Ltd posted an EPS surprise of -192.31% and a revenue surprise of -71.11%.
When is Kiniksa Pharmaceuticals Ltd (KNSA) next earnings report?
Kiniksa Pharmaceuticals Ltd is expected to release its next earnings report on March 31, 2025.